Program News
News and stories about members of the UNC Lineberger Cancer Genetics Research Program
-
Perou elected as fellow of the American Association for Cancer Research Academy
The AACR has elected Charles Perou, PhD, as a fellow to the AACR Academy. Members of this year’s class will be formally recognized at the AACR’s annual meeting.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
-
Ian Davis awarded $1 million by V Foundation
UNC Lineberger’s Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
-
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
-
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
-
Perou presents AACR Distinguished Lectureship in Breast Cancer Research
Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.
-
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
-
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
-
Scientists discover surprise anticancer properties of common lab molecule
Aziz Sancar, MD, PhD, and colleagues report that a common molecular tool for DNA labeling also has anticancer properties worthy of further investigation, especially for brain cancers.
-
UNC Lineberger creates RNA Discovery Center
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
-
Franco explores the human genome in the hunt for novel cancer treatments
Though he aspired for a career in marine biology, UNC Lineberger’s Hector L. Franco, PhD, discovered the field genetics at college, which led him to change his academic focus and earn a doctorate in biochemistry and molecular genetics.
-
Scientists train a computer to classify breast cancer tumors
Using technology similar to the type that powers facial recognition on a smartphone, Charles M. Perou, PhD, Melissa Troester, PhD, and Heather D. Couture have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.
-
Discovery of kidney cancer driver could lead to new treatment strategy
In a study published in the journal Science, researchers led by UNC Lineberger’s Qing Zhang, PhD, suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.